<< Members

Qifeng Bai

Update: January 21, 2017


Qifeng Bai mainly focuses on the drug design, molecular dynamics simulations and cloud computing studies. The detail studies include: designing the agonists and inhibitors of GPCRs and kinase, studying the conformational change of GPCRs by the long molecular dynamics simulations (namd, amber, gromacs) and relative accelerate molecular dynamics simulated methods, skilling the hadoop and jppf frames and applying the cloud computing technology into drug screening. His studies have published on Sci Rep、PCCP、BBA、plos one、molecular biosystem、Mol Pharmacol、Mol Cancer Ther, etc.